Search Results 431-440 of 17376 for alopecia
Toxicities related to prior therapy must have returned to Grade 1 or less, except for alopecia. ... alopecia) not requiring systemic treatment, or ...
... alopecia). Patients must not have had nitrosoureas or mitomycin C for 6 weeks prior to the initiation of study treatment. Radiation: Prior radiation therapy ...
prior therapies (excluding alopecia, neuropathy, and nail changes). - Clinical laboratory values as specified below within 14 days before the first dose of
Patients with vitiligo or alopecia; ... Any unresolved toxicity National Cancer Institute (NCI) CTCAE v 5.0 Grade ≥ 2 from previous anticancer therapy, with the ...
- Adequate organ function (bone marrow, hepatic, renal function and coagulation). - All toxicities (except alopecia) from prior cancer treatments or procedures ...
Dan Childs, M.D., Oncologist: For a long time, we thought advanced prostate cancer was incurable. But now we see some men who have come in with metastatic ...
Find out about adult health, including physical and mental health, relationships, and workplace issues.
Home · Mayo Clinic Division of Endocrinology - Depth and Breadth of Endocrine Expertise ...
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19. 5X My Gift! Find a doctor · Explore careers.
Persistent toxicity from previous treatments that has not resolved to ≤ Common Terminology Criteria for Adverse Events (CTCAE) Grade 1 (except for alopecia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.